CROI 2019: Advances in antiretroviral therapy

Medicine and Dentistry

• Antiretroviral Therapy 100%
• Human Immunodeficiency Virus 57%
• Mortality 28%
• Integrase 28%
• Woman 28%
• Patient 28%
• Donor 28%
• Health Outcomes 14%
• Prevalence 14%
• In Vitro 14%
• HIV/AIDS 14%
• Diagnosis 14%
• Exploratory Behavior 14%
• Opportunistic Infection 14%
• Retrovirus Infection 14%
• Congenital Malformation 14%
• Hematopoietic Stem Cell 14%
• Stem Cell Transplant 14%
• Chemokine Receptor 14%
• Beta Chemokine 14%
• Rilpivirine 14%
• Joint 14%
• Association 14%
• Clotiazepam 14%

Nursing and Health Professions

• Antiretroviral Therapy 100%
• Mortality 28%
• Integrase 28%
• Prevalence 14%
• World Health Organization 14%
• Diagnosis 14%
• Congenital Malformation 14%
• Scale up 14%
• Electric Potential 14%
• Time 14%
• Clotiazepam 14%
• Hospital Service 14%
• Retrovirus Infection 14%
• Opportunistic Infection 14%
• Rilpivirine 14%
• Hormonal Contraception 14%
• Cabotegravir 14%
• Chemokine Receptor 14%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 57%
• Integrase 28%
• Mortality 28%
• Clinical Trial 28%
• Case Report 28%
• Prevalence 14%
• Tolerability 14%
• Retrovirus Infection 14%
• Opportunistic Infection 14%
• Drug-Drug Interaction 14%
• Opioid Overdose 14%
• Chemokine Receptor 14%
• Beta Chemokine 14%
• Congenital Malformation 14%
• Cabotegravir 14%
• Rilpivirine 14%
• Clotiazepam 14%